Open AccessSuccessful concomitant therapy with tofacitinib for anti- melanoma differentiation associated gene 5 antibody-positive rapidly progressive interstitial lung disease with poor prognostic factors
Author(s) -
Tomoaki Machiyama,
Toshikazu Shirai,
Yöko Fujita,
Hiroko Sato,
Hiroshi Fujii,
Tomonori Ishii,
Hideo Harigae
Publication year - 2020
Publication title -
medicine, case reports and study protocols
Language(s) - English
Resource type - Journals
ISSN - 2691-3895
DOI - 10.1097/md9.0000000000000026
Subject(s) - tofacitinib , medicine , concomitant , interstitial lung disease , melanoma , disease , oncology , antibody , lung cancer , immunology , cancer research , lung , rheumatoid arthritis